Donor-derived transmission through lung transplantation of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 carbapenemase during an ongoing healthcare facility outbreak.

Authors :: Bardossy AC
Snavely EA
Nazarian E
Annambhotla P
Basavaraju SV
Pepe D
Maloney M
Musser KA
Haas W
Barros N
Pierce VM
Walters M
Epstein L
Source :: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Apr; Vol. 22 (2), pp. e13256. Date of Electronic Publication: 2020 Feb 28.
Publication Year :: 2020
Abstract: We describe a rare instance of donor-derived OXA-23-producing carbapenem-resistant Acinetobacter baumannii transmission during lung transplantation and the subsequent public health response. This investigation highlights how transplantation can introduce rare multidrug-resistant organisms into different healthcare facilities and regions.<br /> (© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)

Subjects :: Acinetobacter baumannii drug effects
Acinetobacter baumannii enzymology
Carbapenems pharmacology
Drug Resistance, Multiple, Bacterial
Genotype
Health Facilities
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Phenotype
Sputum microbiology
beta-Lactamases
Acinetobacter Infections diagnosis
Acinetobacter Infections transmission
Disease Outbreaks
Lung Transplantation adverse effects
Tissue Donors
beta-Lactam Resistance

Language :: English
ISSN :: 1399-3062
Volume :: 22
Issue :: 2
Database :: MEDLINE
Journal :: Transplant infectious disease : an official journal of the Transplantation Society
Publication Type :: Academic Journal
Accession number :: 32034865
Full Text :: https://doi.org/10.1111/tid.13256

Full Text Access

Tools